Top Markets
Coin of the day
Biostage, Inc. Biostage, Inc.

Biostage, Inc.

BSTG
Rank in Stocks #24986
Biostage, Inc. is a biotechnology enterprise dedicated to developing medical... Biostage, Inc. is a biotechnology enterprise dedicated to developing medical products aimed at curing patients suffering from cancers, injuries, and congenital defects within the gastrointestinal system and respiratory pathways. A primary focus for the company is the advancement of its Biostage Esophageal Implant, specifically designed to address esophageal cancer. Founded in 2009, the organization was formerly known as Harvard Apparatus Regenerative Technology, Inc. before rebranding as Biostage, Inc. in March 2016. Its corporate headquarters are located in Holliston, Massachusetts.
Share Price
$3.95
Last synced: 2023-08-15
Market Cap
$54.45M
Change (1 day)
0.00%
Change (1 year)
0.00%
Country
US
Trade Biostage, Inc. (BSTG)

Category

Earnings for Biostage, Inc. (BSTG)
Earnings in 2026 TTM: 0
According to Biostage, Inc. latest financial reports the company's current earnings are 0. In 2026 the company made an earning of 0, equal to its 2026 earnings that were of 0. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.
Earnings history for Biostage, Inc. from 2026 to 2026
Earnings at the end of each year
Year Earnings Change
Not enough data for the provided dates.
Earnings for similar companies or competitors
Company Earnings Earnings Difference Country
$5.27B -
US
$1.95B -
NL
$1.61B -
AU
- -
CH
$-3.09B -
US